<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Feasibility and Preliminary Experience of Quantitative T2* Mapping at 3.0 T for Detection and Assessment of Aggressiveness of Prostate Cancer" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/feasibility-and-preliminary-experience-of-quantitative-t2-mapping-at-3-0-t-for-detection-and-assess/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/feasibility-and-preliminary-experience-of-quantitative-t2-mapping-at-3-0-t-for-detection-and-assess/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2014-07-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Feasibility and Preliminary Experience of Quantitative T2* Mapping at 3.0 T for Detection and Assessment of Aggressiveness of Prostate Cancer" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T02:43:55+00:00","datePublished":"2014-07-31T17:00:00+00:00","description":"Rationale and Objectives","headline":"Feasibility and Preliminary Experience of Quantitative T2* Mapping at 3.0 T for Detection and Assessment of Aggressiveness of Prostate Cancer","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/feasibility-and-preliminary-experience-of-quantitative-t2-mapping-at-3-0-t-for-detection-and-assess/"},"url":"https://clinicaltree.github.io/posts/feasibility-and-preliminary-experience-of-quantitative-t2-mapping-at-3-0-t-for-detection-and-assess/"}</script><title>Feasibility and Preliminary Experience of Quantitative T2* Mapping at 3.0 T for Detection and Assessment of Aggressiveness of Prostate Cancer | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Feasibility and Preliminary Experience of Quantitative T2* Mapping at 3.0 T for Detection and Assessment of Aggressiveness of Prostate Cancer</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Feasibility and Preliminary Experience of Quantitative T2* Mapping at 3.0 T for Detection and Assessment of Aggressiveness of Prostate Cancer</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1406826000" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Jul 31, 2014 </em> </span> <span> Updated <em class="" data-ts="1681094635" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Lian-Ming Wu MD PhD</a> </em>, <em> <a href="">Xiao-Xi Chen MD</a> </em>, <em> <a href="">Han-Qing Xuan MD</a> </em>, <em> <a href="">Qiang Liu MD</a> </em>, <em> <a href="">Si-Teng Suo MS</a> </em>, <em> <a href="">Jia-Ni Hu PhD</a> </em>, <em> <a href="">Jian-Rong Xu MD PhD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="1224 words"> <em>6 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>To assess the feasibility of quantitative T2* mapping at 3.0 T for prostate cancer detection and to investigate the use of T2* values to characterize tumor aggressiveness, with whole-mount step-section pathologic analysis as the reference standard.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Prostate multiecho T2* was performed in 55 consecutive patients with prostate cancer using a multishot fast-field echo sequence at 3.0 T magnetic resonance imaging. T2* mapping was obtained by exponentially fitting the multiecho T2* images pixel by pixel with different echo times for each slice. Generalized estimating equations were used to test the T2* value difference between normal and malignant prostate regions and the association between T2* value and tumor Gleason scores.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>The T2* values of the cancerous prostatic regions (mean: 42.51 ± 0.65 milliseconds) were significantly lower ( <em>P</em> &lt; .001) than those of the normal prostatic regions (mean: 74.87 ± 0.99 milliseconds). Adopting a threshold value of 59.27 milliseconds, T2* mapping resulted in 94.8% sensitivity and 77.3% specificity in the identification of prostate cancer. A lower mean T2* value was significantly associated with a higher tumor Gleason score (mean T2* values of 53.53, 43.75, 33.66, and 22.95 milliseconds were associated with Gleason score of 3 + 3, 3 + 4, 4 + 3, and ≥8, respectively <em>P</em> &lt; .05).</p><h2 id="conclusions"><span class="mr-2">Conclusions</span><a href="#conclusions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>From these preliminary data, quantitative T2* mapping seems to be a potential method in the characterization of prostate cancer. T2* mapping may provide additional quantitative information that significantly correlated with prostate cancer aggressiveness.</p><p>The prostate is the most common noncutaneous site of cancer among men in the United States . Owing to the increasing awareness of its variable biologic aggressiveness, the biggest challenge in managing patients with newly diagnosed prostate cancer is shifting from tumor detection alone to identifying patients with aggressive disease who would benefit from more radical therapy, while sparing those with indolent cancers.</p><p>Current clinical prostate magnetic resonance imaging (MRI) uses a multiparametric imaging approach to increase the sensitivity and specificity of diagnosis, including T2W-weighted turbo-spin echo (TSE) sequence, diffusion-weighted (DW) imaging, dynamic contrast enhancement (DCE) using gadolinium, and magnetic resonance spectroscopic (MRS) imaging. High-grade prostate cancer demonstrates decreased signal on T2W-TSE images, diffusion restriction, early/intense contrast enhancement with early contrast washout, and increased choline/decreased citrate on MRS . Multiple functional MRI techniques could make MRI a much more powerful tool for noninvasively characterizing prostate cancer. However, practical methods to analyze, interpret, and integrate the large amount of data generated by such a multiparametric approach are still lacking. Furthermore, for DCE-MRI, it required the administration of contrast material. Although DW-MRI is the one most commonly used in clinical prostate MRI protocols, it is still an evolving technique with several limitations to be overcome; these include intrinsic technical difficulties that result in image distortions and susceptibility artifacts and a lack of anatomic information and standardized acquisition and image analysis methods.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="eligibility-criteria-and-patient-characteristics"><span class="mr-2">Eligibility Criteria and Patient Characteristics</span><a href="#eligibility-criteria-and-patient-characteristics" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/FeasibilityandPreliminaryExperienceofQuantitativeT2Mappingat30TforDetectionandAssessmentofAggressivenessofProstateCancer/0_1s20S1076633214001512.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/FeasibilityandPreliminaryExperienceofQuantitativeT2Mappingat30TforDetectionandAssessmentofAggressivenessofProstateCancer/0_1s20S1076633214001512.jpg" alt="Figure 1, Flowchart summarizing patient selection." class="lazyload" data-proofer-ignore></a></p><p>Table 1</p><p>Patient Characteristics</p><p>Characteristic Value Age (years) 56 (43–78) Initial prostate-specific antigen (ng/mL) 6.5 (0.9–107.2) Time between magnetic resonance imaging and prostatectomy (days) 23 (1–181) Patients ( <em>n</em> ) 55 Gleason score Biopsy 3 + 3 19 (35) 3 + 4 23 (42) 4 + 3 8 (15) &gt;4 + 4 5 (9) Prostatectomy 3 + 3 10 (18) 3 + 4 30 (55) 4 + 3 14 (25) &gt;4 + 4 1 (2)</p><p>Data are represented as <em>n</em> (%) or median (range).</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="mri-acquisition"><span class="mr-2">MRI Acquisition</span><a href="#mri-acquisition" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="mri-interpretation"><span class="mr-2">MRI Interpretation</span><a href="#mri-interpretation" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/FeasibilityandPreliminaryExperienceofQuantitativeT2Mappingat30TforDetectionandAssessmentofAggressivenessofProstateCancer/1_1s20S1076633214001512.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/FeasibilityandPreliminaryExperienceofQuantitativeT2Mappingat30TforDetectionandAssessmentofAggressivenessofProstateCancer/1_1s20S1076633214001512.jpg" alt="Figure 2, The relative position of the tumor (T) was translatable and annotated on the T2* mapping, matching the size and distribution of the tumor. ROI, region of interest; ROI (normal) = ROI of the contralateral segment of the normal peripheral zone; ROI (tumor) = ROI of tumor." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="histopathologic-analysis-and-image-correlation"><span class="mr-2">Histopathologic Analysis and Image Correlation</span><a href="#histopathologic-analysis-and-image-correlation" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="statistical-analysis"><span class="mr-2">Statistical Analysis</span><a href="#statistical-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="histopathology-results"><span class="mr-2">Histopathology Results</span><a href="#histopathology-results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="mri-results"><span class="mr-2">MRI Results</span><a href="#mri-results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/FeasibilityandPreliminaryExperienceofQuantitativeT2Mappingat30TforDetectionandAssessmentofAggressivenessofProstateCancer/2_1s20S1076633214001512.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/FeasibilityandPreliminaryExperienceofQuantitativeT2Mappingat30TforDetectionandAssessmentofAggressivenessofProstateCancer/2_1s20S1076633214001512.jpg" alt="Figure 3, Gleason score 6 (3 + 3) tumor of the left and right prostatic apex in a 53-year-old patient is seen as (a) a homogeneous focus of low signal intensity on a transverse T2*-weighted magnetic resonance image (1200/7; outlined in white ) and (b) corresponding T2* mapping." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/FeasibilityandPreliminaryExperienceofQuantitativeT2Mappingat30TforDetectionandAssessmentofAggressivenessofProstateCancer/3_1s20S1076633214001512.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/FeasibilityandPreliminaryExperienceofQuantitativeT2Mappingat30TforDetectionandAssessmentofAggressivenessofProstateCancer/3_1s20S1076633214001512.jpg" alt="Figure 4, Gleason score 7 (4 + 3) tumor of the right prostatic base in a 62-year-old patient is seen as (a) a homogeneous focus of low signal intensity on a transverse T2*-weighted magnetic resonance image (1200/7; outlined in white ) and (b) corresponding T2* mapping." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/FeasibilityandPreliminaryExperienceofQuantitativeT2Mappingat30TforDetectionandAssessmentofAggressivenessofProstateCancer/4_1s20S1076633214001512.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/FeasibilityandPreliminaryExperienceofQuantitativeT2Mappingat30TforDetectionandAssessmentofAggressivenessofProstateCancer/4_1s20S1076633214001512.jpg" alt="Figure 5, Gleason score 8 (4 + 4) tumor of the left peripheral zone in a 71-year-old patient is seen as (a) a homogeneous focus of low signal intensity on a transverse T2*-weighted magnetic resonance image (1200/7; outlined in white ) and (b) corresponding T2* mapping." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/FeasibilityandPreliminaryExperienceofQuantitativeT2Mappingat30TforDetectionandAssessmentofAggressivenessofProstateCancer/5_1s20S1076633214001512.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/FeasibilityandPreliminaryExperienceofQuantitativeT2Mappingat30TforDetectionandAssessmentofAggressivenessofProstateCancer/5_1s20S1076633214001512.jpg" alt="Figure 6, ROC curve demonstrates the discriminating performance of median T2* value in the differentiation between normal and malignant lesions. ROC, receiver operating characteristic." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/FeasibilityandPreliminaryExperienceofQuantitativeT2Mappingat30TforDetectionandAssessmentofAggressivenessofProstateCancer/6_1s20S1076633214001512.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/FeasibilityandPreliminaryExperienceofQuantitativeT2Mappingat30TforDetectionandAssessmentofAggressivenessofProstateCancer/6_1s20S1076633214001512.jpg" alt="Figure 7, Box and whisker plots show T2* value (millimeter) of lesions detected on T2* maps stratified by Gleason score (3 + 3, 3 + 4, 4 + 3, and ≥8). Center line = median; top of box = 75th percentile; bottom of box = 25th percentile; whiskers = 10th and 90th percentiles; and circles = outlier." class="lazyload" data-proofer-ignore></a></p><p>Table 2</p><p>Relationship Between Gleason Score (3 + 3, 3 + 4, 4 + 3, and ≥8) and Mean T2* Values</p><p>Number of Foci Mean T2* Value of the Foci_P_ Value Normal 286 74.87 ± 0.99<em>P</em> &lt; .05 Malignant 286 42.51 ± 0.65 Gleason score = 3 + 3 52 53.53 ± 1.20<em>P</em> &lt; .05 Gleason score = 3 + 4 156 43.75 ± 0.72 Gleason score = 4 + 3 71 33.66 ± 0.81 Gleason score ≥8 7 22.95 ± 1.31</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Jemal A., Siegel R., Xu J., et. al.: Cancer statistics, 2010. CA Cancer J Clin 2010; 60: pp. 277-300.</p><li><p>2. Hricak H., Choyke P.L., Eberhardt S.C., et. al.: Imaging prostate cancer: a multidisciplinary perspective. Radiology 2007; 243: pp. 28-53.</p><li><p>3. Mazaheri Y., Shukla-Dave A., Muellner A., et. al.: MR imaging of the prostate in clinical practice. MAGMA 2008; 21: pp. 379-392.</p><li><p>4. Turkbey B., Albert P.S., Kurdziel K., et. al.: Imaging localized prostate cancer: current approaches and new developments. AJR Am J Roentgenol 2009; 192: pp. 1471-1480.</p><li><p>5. Ghugre N.R., Enriquez C.M., Coates T.D., et. al.: Improved R2* measurements in myocardial iron overload. J Magn Reson Imaging 2006; 23: pp. 9-16.</p><li><p>6. Mamisch T.C., Hughes T., Mosher T.J., et. al.: T2 star relaxation times for assessment of articular cartilage at 3 T: a feasibility study. Skeletal Radiol 2012; 41: pp. 287-292.</p><li><p>7. Hardman R.L., El-Merhi F., Jung A.J., et. al.: Fast T2*-weighted MRI of the prostate at 3 Tesla. J Magn Reson Imaging 2011; 33: pp. 902-907.</p><li><p>8. Korteweg M.A., Zwanenburg J.J., Hoogduin J.M., et. al.: Dissected sentinel lymph nodes of breast cancer patients: characterization with high-spatial-resolution 7-T MR imaging. Radiology 2011; 261: pp. 127-135.</p><li><p>9. Apprich S., Mamisch T.C., Welsch G.H., et. al.: Evaluation of articular cartilage in patients with femoroacetabular impingement (FAI) using T2* mapping at different time points at 3.0 Tesla MRI: a feasibility study. Skeletal Radiol 2012; 41: pp. 987-995.</p><li><p>10. Liney G.P., Knowles A.J., Manton D.J., et. al.: Comparison of conventional single echo and multi-echo sequences with a fast spin-echo sequence for quantitative T2 mapping: application to the prostate. J Magn Reson Imaging 1996; 6: pp. 603-607.</p><li><p>11. Liney G.P., Lowry M., Turnbull L.W., et. al.: Proton MR T2 maps correlate with the citrate concentration in the prostate. NMR Biomed 1996 Apr; 9: pp. 59-64.</p><li><p>12. Roebuck J.R., Haker S.J., Mitsouras D., et. al.: Carr-Purcell-Meiboom-Gill imaging of prostate cancer: quantitative T2 values for cancer discrimination. Magn Reson Imaging 2009 May; 27: pp. 497-502.</p><li><p>13. Langer D.L., van der Kwast T.H., Evans A.J., et. al.: Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI. J Magn Reson Imaging 2009; 30: pp. 327-334.</p><li><p>14. Haacke E.M., Mittal S., Wu Z., et. al.: Susceptibility-weighted imaging: technical aspects and clinical applications, part 1. AJNR Am J Neuroradiol 2009; 30: pp. 19-30.</p><li><p>15. Harada T., Tanigawa N., Matsuki M., et. al.: Evaluation of lymph node metastases of breast cancer using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging. Eur J Radiol 2007 Sep; 63: pp. 401-407.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-21/'>Volume 21</a>, <a href='/categories/issue-8/'>Issue 8</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Feasibility%20and%20Preliminary%20Experience%20of%20Quantitative%20T2*%20Mapping%20at%203.0%20T%20for%20Detection%20and%20Assessment%20of%20Aggressiveness%20of%20Prostate%20Cancer%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Ffeasibility-and-preliminary-experience-of-quantitative-t2-mapping-at-3-0-t-for-detection-and-assess%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Feasibility%20and%20Preliminary%20Experience%20of%20Quantitative%20T2*%20Mapping%20at%203.0%20T%20for%20Detection%20and%20Assessment%20of%20Aggressiveness%20of%20Prostate%20Cancer%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Ffeasibility-and-preliminary-experience-of-quantitative-t2-mapping-at-3-0-t-for-detection-and-assess%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Ffeasibility-and-preliminary-experience-of-quantitative-t2-mapping-at-3-0-t-for-detection-and-assess%2F&text=Feasibility%20and%20Preliminary%20Experience%20of%20Quantitative%20T2*%20Mapping%20at%203.0%20T%20for%20Detection%20and%20Assessment%20of%20Aggressiveness%20of%20Prostate%20Cancer%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/a-multiobserver-study-of-the-effects-of-including-point-of-care-patient-photographs-with-portable-ra/"><div class="card-body"> <em class="small" data-ts="1406826000" data-df="ll" > Jul 31, 2014 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>A Multiobserver Study of the Effects of Including Point-of-care Patient Photographs with Portable Radiography</h3><div class="text-muted small"><p> Rationale and Objectives To evaluate whether the presence of facial photographs obtained at the point-of-care of portable radiography leads to increased detection of wrong-patient errors. Materia...</p></div></div></a></div><div class="card"> <a href="/posts/a-workflow-to-improve-the-alignment-of-prostate-imaging-with-whole-mount-histopathology/"><div class="card-body"> <em class="small" data-ts="1406826000" data-df="ll" > Jul 31, 2014 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>A Workflow to Improve the Alignment of Prostate Imaging with Whole-mount Histopathology</h3><div class="text-muted small"><p> Rationale and Objectives Evaluation of prostate imaging tests against whole-mount histology specimens requires accurate alignment between radiologic and histologic data sets. Misalignment results ...</p></div></div></a></div><div class="card"> <a href="/posts/automated-percentage-of-breast-density-measurements-for-full-field-digital-mammography-applications/"><div class="card-body"> <em class="small" data-ts="1406826000" data-df="ll" > Jul 31, 2014 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Automated Percentage of Breast Density Measurements for Full-field Digital Mammography Applications</h3><div class="text-muted small"><p> Rationale and Objectives Increased mammographic breast density is a significant risk factor for breast cancer. A reproducible, accurate, and automated breast density measurement is required for fu...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/dual-energy-kub-radiographic-examination-for-the-detection-of-renal-calculus/" class="btn btn-outline-primary" prompt="Older"><p>Dual-energy KUB Radiographic Examination for the Detection of Renal Calculus</p></a> <a href="/posts/highly-cited-works-in-radiology/" class="btn btn-outline-primary" prompt="Newer"><p>Highly Cited Works in Radiology</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
